MedPath

Research on the Application of Patient Navigation-based Management Model of Patients After LEEP

Not Applicable
Not yet recruiting
Conditions
Cervical Intraepithelial Neoplasias
Registration Number
NCT06695871
Lead Sponsor
Peking University People's Hospital
Brief Summary

Cervical cancer poses a significant threat to women's health and is a crucial public health issue. Early detection and treatment of cervical lesions and standardized management have emerged as essential pillars in the Global Cervical Cancer Elimination. The loop electrosurgical excision procedure (LEEP) is widely employed as a preferred approach for the diagnosis and treatment of precancerous cervical lesions and early invasive cervical cancer. Patients with high-grade cervical lesions are more prone to experiencing sexual dysfunction and psychological disorders after LEEP, attributed to the unique surgical site, physiological alterations, and psychological stress during the postoperative recovery process, thereby adversely affecting their quality of life. Currently, there is a shortage of research evidence regarding targeted intervention measures and long-term effect evaluations for sexual function quality and quality of life after LEEP for cervical lesions. In recent years, the health management model based on patient navigation has evolved into a novel modality for facilitating comprehensive tumor prevention and control. However, its effect in managing cervical lesions has yet to be comprehensively assessed. Therefore, we will design a randomized controlled trial to evaluate the impact of a patient navigation-based health management model on quality of life and sexual function after LEEP in patients with cervical lesions.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
128
Inclusion Criteria
  • Individuals aged between 25 and 50 years;
  • LEEP will be conducted following clinical evaluation;
  • No intention to conceive within the subsequent year;
  • Proficiency in utilizing social media platforms, such as WeChat, is required;
  • Patients must be capable of providing informed consent to participate in the study and willing to engage in long-term follow-up.
Exclusion Criteria
  • Individuals who are widowed, separated, or experiencing atypical sexual activity due to reasons related to their spouse.
  • Presence of genital tract malformations.
  • A history of neurological disorders, such as stroke or epilepsy, or a history of psychiatric conditions, such as depression.
  • Patients with other significant illnesses that could impact the long-term follow-up of the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Quality of Lifesix months after LEEP

The quality of life six months post-surgery was assessed using 36-Item Short Form Survey.

Secondary Outcome Measures
NameTimeMethod
Sexual function indexbefore LEEP, three months after LEEP, and six months after LEEP

The Chinese version of the Female Sexual Function Index was used to evaluate the sexual function index at three time points: before LEEP, three months after LEEP, and six months after LEEP.

Anxietybefore LEEP, three months after LEEP, and six months after LEEP

Anxiety symptoms were assessed using the Self-Rating Anxiety Scale at three-time points: before LEEP, three months after LEEP, and six months after LEEP.

Quality of Lifebefore LEEP and three months after LEEP

The quality of life was assessed using 36-Item Short Form Survey.

Depressionbefore LEEP, three months after LEEP, and six months after LEEP

Depression symptoms were assessed using the Self-Rating Anxiety Scale at three time points: before LEEP, three months after LEEP, and six months after LEEP.

Vaginal dischargethree and six months after LEEP

Patient-reported alterations in the volume, color, and odor of vaginal secretions.

Recurrence ratesthree and six months after LEEP

The recurrence of cervical lesions at three and six months post-surgery was evaluated using high-risk HPV testing, cytology test, and histopathological examination.

Trial Locations

Locations (1)

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath